Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Prepaid Assets of $10.7 million for Q2 2026, up 16.07% on a QoQ basis from $9.2 million in Q1 2026, and up 8.27% year-over-year from $9.9 million in Q2 2025.
Analysis
Tonix Pharmaceuticals Holding (TNXP) Prepaid Assets (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Prepaid Assets for 17 years, with the latest figure at $10.7 million in Q2 2026.
- On a quarterly basis, Prepaid Assets rose 8.27% year-over-year to $10.7 million in Q2 2026; TTM through Jun 2026 was $10.7 million, a 8.27% increase from a year earlier, with the FY2025 full-year figure at $9.0 million, up 10.08% from the prior year.
- Prepaid Assets was $10.7 million for Q2 2026 at Tonix Pharmaceuticals Holding, up from $9.2 million in the prior quarter.
- The five-year high for Prepaid Assets was $14.8 million in Q2 2022, with the low at $6.4 million in Q1 2025.
- Average Prepaid Assets over 5 years is $10.2 million, with a median of $10.1 million recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Prepaid Assets slumped 40.09% in 2025, then soared 44.06% in 2026.
- Over 5 years, Prepaid Assets stood at $10.5 million in 2022, then dropped by 12.96% to $9.2 million in 2023, then decreased by 11.39% to $8.1 million in 2024, then advanced by 10.08% to $9.0 million in 2025, then gained by 19.68% to $10.7 million in 2026.
- The last three Prepaid Assets figures came in at $10.7 million (Q2 2026), $9.2 million (Q1 2026), and $9.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.72 Mn |
| Mar 31, 2026 | 9.23 Mn |
| Dec 31, 2025 | 8.96 Mn |
| Sep 30, 2025 | 8.81 Mn |
| Jun 30, 2025 | 9.90 Mn |
| Mar 31, 2025 | 6.41 Mn |
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | 10.37 Mn |
| Jun 30, 2024 | 8.34 Mn |
| Mar 31, 2024 | 10.70 Mn |
| Dec 31, 2023 | 9.18 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 12.01 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 10.55 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 14.77 Mn |
| Mar 31, 2022 | 12.55 Mn |
| Dec 31, 2021 | 10.39 Mn |
| Sep 30, 2021 | 12.11 Mn |